IMPORTANT NOTE: You may submit your article only through our online submission systemSubmit your manuscript
  • Slider Image

Reviews 2005-2018

Diabetes and Oral Oncogenesis.
Darbepoetin Alpha Coming of Age.
P. PEDRAZZOLI, S. CINIERI, V. LORUSSO, T. GAMUCCI, S. SECONDINO, N. SILVESTRIS (Milan; Lecce; Sora; Bari, Italy). Anticancer Res 27: 4419-4424, 2007.
Aberrant Crypt Foci.
S.J. ALRAWI, M. SCHIFF, R.E. CARROLL, M. DAYTON, J.F. GIBBS, M. KULAVLAT, D. TAN, K. BERMAN, D.L. STOLER, G.R. ANDERSON (Buffalo, NY; Chicago IL, USA). Anticancer Res 26: 107-120, 2006.
Primary Lymphomas of Bone.
P. KITSOULIS, M. VLYCHOU, A. PAPOUDOU-BAI, G. KARATZIAS, A. CHARCHANTI, N.J. AGNANTIS, M. BAI (Ioannina; Larissa, Greece). Anticancer Res 26: 325-338, 2006.
Prospect for Anti-HER2 Receptor Therapy in Breast Cancer.
F.-X. BRAND, N. RAVANEL, A.-S. GAUCHEZ, D. PASQUIER, R. PAYAN, D. FAGRET, M. MOUSSEAU (Grenoble; St. Martin d'Hères France). Anticancer Res 26: 463-470, 2006.
External Beam Radiotherapy for Prostate Cancer: Current Position and Trends.
M.I. KOUKOURAKIS, S. TOULOUPIDIS (Alexandroupolis, Greece). Anticancer Res 26: 485-494, 2006.
Sequential Versus Concurrent Chemo-radiotherapy in Inoperable Stage III Non-small Cell Lung Cancer.
S.Y. EL SHAROUNI, H.B. KAL, J.J. BATTERMANN, F.M.N.H. SCHRAMEL (Utrecht; Nieuwegein, The Netherlands). Anticancer Res 26: 495-506, 2006.
Stable Disease in Advanced Colorectal Cancer: Therapeutic Implications.
L.M. PASETTO, M.R. D’ANDREA, A. JIRILLO, E. ROSSI, S. MONFARDINI (Padova; Noale, Italy). Anticancer Res 26: 511-522, 2006.
Surgery for Advanced and Metastatic Pancreatic Cancer – Current State and Perspectives.
O. MANN, T. STRATE, C. SCHNEIDER, E.F. YEKEBAS, J.R. IZBICKI (Hamburg-Eppendorf, Germany). Anticancer Res 26: 681-686, 2006.
Prospect for Anti-Her2 Receptor Therapy in Breast Cancer.
F.-X. BRAND, N. RAVANEL, A.-S. GAUCHEZ, D. PASQUIER, R. PAYAN, D. FAGRET, M. MOUSSEAU (Grenoble; St. Martin d'Hères, France). Anticancer Res 26: 715-722, 2006.
Cancer Genetics of Sporadic Colorectal Cancer: BRAF and PI3KCA Mutations, their Impact on Signaling and Novel Targeted Therapies.
E. OIKONOMOU, A. PINTZAS (Athens, Greece). Anticancer Res 26: 1077-1084, 2006.
Molecular Immunological Approaches to Biotherapy of Human Cancers – A Review, Hypothesis and Implications.
Y. BECKER (Jerusalem, Israel). Anticancer Res 26: 1113-1134, 2006.
A Related Donor and Reduced Intensity Conditioning Reduces the Risk of Development of BK Virus-positive Haemorrhagic Cystitis in Allogeneic Haematopoetic Stem Cell- transplanted Patients.
G. BOGDANOVIC, P. PRIFTAKIS, G. GIRAUD, T. DALIANIS (Stockholm, Sweden). Anticancer Res 26: 1311-1318, 2006.
Alkylating Agents and DNA Polymerases.
L.P. BIGNOLD (Adelaide, SA, Australia). Anticancer Res 26: 1327-1336, 2006.
Chemotherapy Treatment Options for Elderly Women with Breast Cancer.
S. KÜMMEL, D. ELLING, S. JESCHKE, P. SCHMID, A. THOMAS (Berlin, Germany). Anticancer Res 26: 1673-1676, 2006.
Options and Limits of Surgery after Pre-operative Chemotherapy in Breast Cancer.
A. THOMAS, R. OHLINGER, M. HAUSCHILD, A. MUSTEA, J.-U. BLOHMER, S. KÜMMEL (Berlin, Germany). Anticancer Res 26: 1677-1682, 2006.
The Orphan Nuclear Receptors, Estrogen Receptor-related Receptors: their Role as New Biomarkers in Gynecological Cancer.
P. SUN, L. WEI, C. DENKERT, W. LICHTENEGGER, J. SEHOULI (Beijing, China; Berlin, Germany). Anticancer Res 26: 1699-1706, 2006.
Postoperative Therapy Modalities for Cervical Carcinoma.
S. KÜMMEL, A. THOMAS, S. JESCHKE, M. HAUSCHILD, J. SEHOULI, W. LICHTENEGGER, J.-U. BLOHMER (Berlin, Germany). Anticancer Res 26: 1707-1714, 2006.
The Role of Capecitabine in the Treatment of Colorectal Cancer in the Elderly.
L.M. PASETTO, S. MONFARDINI (Padova, Italy). Anticancer Res 26: 2381-2386, 2006.
Vitamin D and Cancer.
C.S. SPINA, V. TANGPRICHA, M. USKOKOVIC, L. ADORINIC, H. MAEHR, M.F. HOLICK (Boston, MA; Atlanta, GA; Nutley, NJ, USA). Anticancer Res 26: 2515- 2524, 2006.
Mechanisms of Vitamin D-mediated Growth Inhibition in Prostate Cancer Cells: Inhibition of the Prostaglandin Pathway.
J. MORENO, A.V. KRISHNAN, D.M. PEEHL, D. FELDMAN (Stanford, CA, USA). Anticancer Res 26: 2525-2530, 2006.
Vitamin D Compounds: Activity Against Microbes and Cancer.
A.F. GOMBART, Q.T. LUONG, H. P. KOEFFLER (Los Angeles, CA, USA). Anticancer Res 26: 2531-2542, 2006.
The Antitumor Efficacy of Calcitriol: Preclinical Studies.
C.S. JOHNSON, J.R. MUINDI, P.A. HERSHBERGER, D.L. TRUMP (Buffalo, NY; Pittsburgh, PA, USA). Anticancer Res 26: 2543-2550, 2006.
Vitamin D Compounds: Clinical Development as Cancer Therapy and Prevention Agents.
D.L. TRUMP, J. MUINDI, M. FAKIH, W.-D. YU, C.S. JOHNSON (Buffalo, NY, USA). Anticancer Res 26: 2551-2556, 2006.
Epigenetic Corruption of VDR Signalling in Malignancy.
S.A. ABEDIN, C.M. BANWELL, K.W. COLSTON, C. CARLBERG, M.J. CAMPBELL (Birmingham; London, UK; Kuopio, Finland). Anticancer Res 26: 2557-2566, 2006.
Dysfunction of the Vitamin D Endocrine System as Common Cause for Multiple Malignant and other Chronic Diseases.
M. PETERLIK, H.S. CROSS (Vienna, Austria). Anticancer Res 26: 2581-2588, 2006.
The Impact of Chromatin Organization of Vitamin D Target Genes.
C. CARLBERG, T.W. DUNLOP (Kuopio, Finland). Anticancer Res 26: 2637-2646, 2006.
Calcitriol in the Treatment of Prostate Cancer.
T.M. BEER, A. MYRTHUE (Portland, OR, USA). Anticancer Res 26: 2647-2652, 2006.
Selective Inhibitors of Vitamin D Metabolism – New Concepts and Perspectives.
I. SCHUSTER, H. EGGER, G. HERZIG, G.S. REDDY, J.A. SCHMID, M. SCHÜSSLER, G. VORISEK (Vienna, Austria; Providence, RI, USA). Anticancer Res 26: 2653-2668, 2006.
Effects of 1—,25-Dihydroxyvitamin D3 in Human Colon Cancer Cells.
J.M. GONZÁLEZ- SANCHO, M.J. LARRIBA, P. ORDÓÑEZ-MORÁN, H.G. PÁLMER, A. MUÑOZ (Madrid, Spain; London, UK). Anticancer Res 26: 2669-2682, 2006.
Vitamin D Analogs and Coactivators.
G. EELEN, L. VERLINDEN, P. DE CLERCQ, M. VANDEWALLE, R. BOUILLON, A. VERSTUYF (Leuven; Gent, Belgium). Anticancer Res 26: 2717-2722, 2006.
UV Radiation and Cancer Prevention: What is the Evidence?
R. KRAUSE, B. MATULLA- NOLTE, M. ESSERS, A. BROWN, W. HOPFEN MÜLLER (Berlin, Germany). Anticancer Res 26: 2723-2728, 2006.
Cutaneous Photosynthesis of Vitamin D: An Evolutionary Highly-conserved Endocrine System that Protects against Environmental Hazards Including UV-radiation and Microbial Infections.
L. TREMEZAYGUES, M. STICHERLING, C. PFÖHLER, M. FRIEDRICH, V. MEINEKE, M. SEIFERT, W. TILGEN, J. REICHRATH (Homburg/Saar; Leipzig; Lübeck; München, Germany). Anticancer Res 26: 2743-2748, 2006.
Role of Surgery in Treatment of Locally Advanced Prostate Cancer.
D. PREZIOSO, R. GALASSO, M. DI MARTINO, G. IAPICCA, F. IACONO (Naples, Italy). Anticancer Res 26: 3151- 3158, 2006.
Proteomics in the Diagnosis of Hepatocellular Carcinoma: Focus on High Risk Hepatitis B and C Patients.
A. EL-ANEED, J. BANOUB (St. John’s, NL, Canada). Anticancer Res 26: 3293- 3300, 2006.
New Molecular Mechanisms of Action of Camptothecin-type Drugs.
K. LEGARZA, L.-X. YANG (San Francisco, CA, USA). Anticancer Res 26: 3301-3306, 2006.
Recent Progress in Target Therapy in Colorectal Cancer.
L.M. PASETTO, A. BORTOLAMI, C. FALCI, G. SINIGAGLIA, S. MONFARDINI (Padova; Aviano, Italy). Anticancer Res 26: 3973- 3982, 2006.
The Therapeutic Potential of Immuno-cell Therapy of Cancer in Combination with Aminobisphosphonates.
S. GOTO, A. NOGUCHI, H. JINGUJI, M. TAKAHARA (Tokyo, Japan). Anticancer Res 26: 3989-3996, 2006.
Unique Molecular Characteristics of the Environmental Responses of Mucosal Macrophages.
K. NAKATA, H. INAGAWA, T. NISHIZAWA, C. KOHCHI, Y. TANIGUCHI, N. YOSHIOKA, G.-I. SOMA (Tokushima; Shimonoseki; Chiba, Japan). Anticancer Res 26: 4009- 4014, 2006.
Possible Applications of Antibodies or their Genes in Cancer Therapy.
M. KUROKI, J. HUANG, H. SHIBAGUCHI, T. TANAKA, J. ZHAO, N. LUO, K. HACHIMINE, T. KINUGASA, S.-I. MAEKAWA, S. ENATSU, W. HAMANAKA, T. FUKAMI, M. KUROKI (Fukuoka, Japan). Anticancer Res 26: 4019- 4026, 2006.
HER-2 and NF-κB as the Targets for Therapy-resistant Breast Cancer.
K.M. AHMED, N. CAO, J.J. LI (West Lafayette, IN, USA). Anticancer Res 26: 4235-4244, 2006.
The Emerging World of MicroRNAs.
L. O’DRISCOLL (Dublin, Ireland). Anticancer Res 26: 4271- 4278, 2006.
Anticancer Potential of Silymarin: From Bench to Bed Side.
R. AGARWAL, C. AGARWAL, H. ICHIKAWA, R.P. SINGH, B.B. AGGARWAL (Denver, CO; Houston, TX, USA). Anticancer Res 26: 4457-4498, 2006.
Hepatic Metastases of Colorectal Cancer: Locoregional Intra-arterial Treatment.
L.M. PASETTO, R. MERENDA, P. PILATI, G. SINIGAGLIA, S. MONFARDINI (Padova, Italy). Anticancer Res 26: 4785-4792, 2006.
Ovarian Cancer Screening.
M. KYRGIOU, I. TSOUMPOU, P. MARTIN-HIRSCH, M. ARBYN, W. PRENDIVILLE, G. KOLIOPOULOS, N. DALKALITSIS, P. STAMATOPOULOS, E. PARASKEVAIDIS (London; Edinburgh; Preston; Oxford, UK; Brussels, Belgium; Lyon, France; Dublin, Ireland; Ioannina; Thessaloniki, Greece). Anticancer Res 26: 4793-4802, 2006.
Parathyroid Cancer: Etiology, Clinical Presentation and Treatment.
F. LUMACHI, S.M.M. BASSO, U. BASSO (Padova, Italy). Anticancer Res 26: 4803-4808, 2006.
Adjuvant Chemotherapy for Colon Cancer.
A.G. PALLIS, I.A. MOUZAS (Heraklion, Greece). Anticancer Res 26: 4809-4816, 2006.
B-cell Differentiation, Apoptosis and Proliferation in Diffuse Large B-cell Lymphomas.
M. BAI, A. SKYRLAS, N.J. AGNANTIS, S. KAMINA, A. PAPOUDOU-BAI, P. KITSOULIS, P. KANAVAROS (Ioannina, Greece). Anticancer Res 25: 347-362, 2005.
Prostate Cancer Therapy: Standard Management, New Options and Experimental Approaches.
L. TROJAN, K. KIKNAVELIDZE, T. KNOLL, P. ALKEN, M.S. MICHEL (Mannheim, Germany). Anticancer Res 25: 551-562, 2005.
FOLFOX Versus FOLFIRI: A Comparison of Regimens in the Treatment of Colorectal Cancer Metastases.
L.M. PASETTO, A. JIRILLO, G. IADICICCO, E. ROSSI, M.K. PARIS, S. MONFARDINI (Padova, Italy). Anticancer Res 25: 563-576, 2005.
Page: 1 2 3 4 5 6 ... 7 8 9 10 11 12 
Custom Tables Plugin 05a1a29bdcae7b12229e651a9fd48b11

IMPORTANT NOTE: You may submit your article only through our online submission system